Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-009446
Filing Date
2024-02-01
Accepted
2024-02-01 16:05:20
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 tm244399-1_s3.htm S-3 364190
2 GRAPHIC lg_annovis-4c.jpg GRAPHIC 36582
3 EXHIBIT 4.5 tm244399d2_ex4-5.htm EX-4.5 341183
4 EXHIBIT 23.1 tm244399d2_ex23-1.htm EX-23.1 2749
5 EX-FILING FEES tm244399d2_ex-filingfees.htm EX-FILING FEES 64532
  Complete submission text file 0001104659-24-009446.txt   824251
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276814 | Film No.: 24586894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)